Cargando…
Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization
Activating mutations of epidermal growth factor receptor (EGFR) play crucial roles in the oncogenesis of human non-small cell lung cancer (NSCLC). By screening 79 commercially available natural products, we found that the natural compound deguelin exhibited a profound anti-tumor effect on NSCLC via...
Autores principales: | Gao, Feng, Yu, Xinfang, Li, Ming, Zhou, Li, Liu, Wenbin, Li, Wei, Liu, Haidan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035355/ https://www.ncbi.nlm.nih.gov/pubmed/32081857 http://dx.doi.org/10.1038/s41419-020-2344-0 |
Ejemplares similares
-
Deguelin suppresses angiogenesis in human hepatocellular carcinoma by targeting HGF-c-Met pathway
por: Li, Ming, et al.
Publicado: (2017) -
Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma
por: Yu, Xinfang, et al.
Publicado: (2017) -
Oxymatrine inhibits non–small cell lung cancer via suppression of EGFR signaling pathway
por: Li, Wei, et al.
Publicado: (2017) -
Repression of Noxa by Bmi1 contributes to deguelin‐induced apoptosis in non‐small cell lung cancer cells
por: Li, Wei, et al.
Publicado: (2018) -
ERK kinase phosphorylates and destabilizes the tumor suppressor FBW7 in pancreatic cancer
por: Ji, Shunrong, et al.
Publicado: (2015)